A subsidiary of Switzerland-based pharmaceutical giant Novartis is making a major investment in central Indiana. Advanced Accelerator Applications plans to build a $72 million production facility at the Purdue Research Park of Indianapolis. A critical business connection in West Lafayette played a key role in landing the deal. Advanced Accelerator Applications General Manager Mike Rossi explains in this week’s Business of Health.

Video Player is loading.
Advertisement
Current Time 0:00
Duration -:-
Loaded: 0%
Stream Type LIVE
Remaining Time -:-
1x

    Your go-to for Indiana business news.

    Try us out for

    $1/week

    Cancel anytime

    Subscribe Now

    Already a paid subscriber? Log In